Diagnosis of Non-Muscle Invasive Bladder Cancer

Joan Palou, Andreas Böhle, J. Alfred Witjes, Marc Colombel, Maurizio Brausi, Donald Lamm, Raj Persad, Roger Buckley, Hideyuki Akaza, Mark Soloway

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Context: Early detection and diagnosis improves both the management and survival of patients with non-muscle invasive bladder cancer (NMIBC). Objective: To provide a review of current approaches to the diagnosis of NMIBC as well as practical recommendations. Evidence acquisition: A committee of internationally renowned leaders in bladder cancer management, known as the International Bladder Cancer Group (IBCG), was convened in October 2006 to review current literature surrounding the diagnosis of NMIBC as well as the current clinical practice guidelines of the European Association of Urology (EAU), the First International Consultation of Bladder Tumours (FICBT), the National Comprehensive Cancer Network (NCCN), and the American Urological Association (AUA). Following the inaugural meeting in October 2006, the IBCG met on three subsequent occasions to exchange ideas and develop uniform and practical recommendations for the diagnosis of NMIBC. Evidence synthesis: The IBCG provided practical recommendations for the assessment and diagnosis of NMIBC. Conclusions: The diagnosis of NMIBC is ultimately made by transurethral resection of the bladder tumour (TURBT). Cystoscopy should be performed in all patients, and the aspect, number, shape, size, and location of the tumour should be documented. Ultrasonography and/or intravenous urography/computed tomography-urogram should only be used in select patients with multiple or trigonal tumours. A repeat TURBT is recommended in high-grade T1 tumours or if the initial resection was incomplete and/or when there is no muscle in the specimen.

Original languageEnglish
Pages (from-to)627-636
Number of pages10
JournalEuropean Urology, Supplements
Volume7
Issue number10
DOIs
StatePublished - Oct 1 2008
Externally publishedYes

Fingerprint

Urinary Bladder Neoplasms
Urography
Neoplasms
Cystoscopy
Practice Guidelines
Early Diagnosis
Ultrasonography
Referral and Consultation
Tomography

Keywords

  • Bladder biopsies
  • Bladder tumour markers
  • Computed tomography
  • Cystoscopy
  • Diagnosis of non-muscle invasive bladder cancer
  • Intravenous urography
  • Magnetic resonance imaging
  • Transurethral resection of the bladder tumour
  • Ultrasonography

ASJC Scopus subject areas

  • Urology

Cite this

Palou, J., Böhle, A., Witjes, J. A., Colombel, M., Brausi, M., Lamm, D., ... Soloway, M. (2008). Diagnosis of Non-Muscle Invasive Bladder Cancer. European Urology, Supplements, 7(10), 627-636. https://doi.org/10.1016/j.eursup.2008.07.005

Diagnosis of Non-Muscle Invasive Bladder Cancer. / Palou, Joan; Böhle, Andreas; Witjes, J. Alfred; Colombel, Marc; Brausi, Maurizio; Lamm, Donald; Persad, Raj; Buckley, Roger; Akaza, Hideyuki; Soloway, Mark.

In: European Urology, Supplements, Vol. 7, No. 10, 01.10.2008, p. 627-636.

Research output: Contribution to journalArticle

Palou, J, Böhle, A, Witjes, JA, Colombel, M, Brausi, M, Lamm, D, Persad, R, Buckley, R, Akaza, H & Soloway, M 2008, 'Diagnosis of Non-Muscle Invasive Bladder Cancer', European Urology, Supplements, vol. 7, no. 10, pp. 627-636. https://doi.org/10.1016/j.eursup.2008.07.005
Palou J, Böhle A, Witjes JA, Colombel M, Brausi M, Lamm D et al. Diagnosis of Non-Muscle Invasive Bladder Cancer. European Urology, Supplements. 2008 Oct 1;7(10):627-636. https://doi.org/10.1016/j.eursup.2008.07.005
Palou, Joan ; Böhle, Andreas ; Witjes, J. Alfred ; Colombel, Marc ; Brausi, Maurizio ; Lamm, Donald ; Persad, Raj ; Buckley, Roger ; Akaza, Hideyuki ; Soloway, Mark. / Diagnosis of Non-Muscle Invasive Bladder Cancer. In: European Urology, Supplements. 2008 ; Vol. 7, No. 10. pp. 627-636.
@article{1e7a4bba9ad043b1b847ac726ad49e67,
title = "Diagnosis of Non-Muscle Invasive Bladder Cancer",
abstract = "Context: Early detection and diagnosis improves both the management and survival of patients with non-muscle invasive bladder cancer (NMIBC). Objective: To provide a review of current approaches to the diagnosis of NMIBC as well as practical recommendations. Evidence acquisition: A committee of internationally renowned leaders in bladder cancer management, known as the International Bladder Cancer Group (IBCG), was convened in October 2006 to review current literature surrounding the diagnosis of NMIBC as well as the current clinical practice guidelines of the European Association of Urology (EAU), the First International Consultation of Bladder Tumours (FICBT), the National Comprehensive Cancer Network (NCCN), and the American Urological Association (AUA). Following the inaugural meeting in October 2006, the IBCG met on three subsequent occasions to exchange ideas and develop uniform and practical recommendations for the diagnosis of NMIBC. Evidence synthesis: The IBCG provided practical recommendations for the assessment and diagnosis of NMIBC. Conclusions: The diagnosis of NMIBC is ultimately made by transurethral resection of the bladder tumour (TURBT). Cystoscopy should be performed in all patients, and the aspect, number, shape, size, and location of the tumour should be documented. Ultrasonography and/or intravenous urography/computed tomography-urogram should only be used in select patients with multiple or trigonal tumours. A repeat TURBT is recommended in high-grade T1 tumours or if the initial resection was incomplete and/or when there is no muscle in the specimen.",
keywords = "Bladder biopsies, Bladder tumour markers, Computed tomography, Cystoscopy, Diagnosis of non-muscle invasive bladder cancer, Intravenous urography, Magnetic resonance imaging, Transurethral resection of the bladder tumour, Ultrasonography",
author = "Joan Palou and Andreas B{\"o}hle and Witjes, {J. Alfred} and Marc Colombel and Maurizio Brausi and Donald Lamm and Raj Persad and Roger Buckley and Hideyuki Akaza and Mark Soloway",
year = "2008",
month = "10",
day = "1",
doi = "10.1016/j.eursup.2008.07.005",
language = "English",
volume = "7",
pages = "627--636",
journal = "European Urology, Supplements",
issn = "1569-9056",
publisher = "Elsevier",
number = "10",

}

TY - JOUR

T1 - Diagnosis of Non-Muscle Invasive Bladder Cancer

AU - Palou, Joan

AU - Böhle, Andreas

AU - Witjes, J. Alfred

AU - Colombel, Marc

AU - Brausi, Maurizio

AU - Lamm, Donald

AU - Persad, Raj

AU - Buckley, Roger

AU - Akaza, Hideyuki

AU - Soloway, Mark

PY - 2008/10/1

Y1 - 2008/10/1

N2 - Context: Early detection and diagnosis improves both the management and survival of patients with non-muscle invasive bladder cancer (NMIBC). Objective: To provide a review of current approaches to the diagnosis of NMIBC as well as practical recommendations. Evidence acquisition: A committee of internationally renowned leaders in bladder cancer management, known as the International Bladder Cancer Group (IBCG), was convened in October 2006 to review current literature surrounding the diagnosis of NMIBC as well as the current clinical practice guidelines of the European Association of Urology (EAU), the First International Consultation of Bladder Tumours (FICBT), the National Comprehensive Cancer Network (NCCN), and the American Urological Association (AUA). Following the inaugural meeting in October 2006, the IBCG met on three subsequent occasions to exchange ideas and develop uniform and practical recommendations for the diagnosis of NMIBC. Evidence synthesis: The IBCG provided practical recommendations for the assessment and diagnosis of NMIBC. Conclusions: The diagnosis of NMIBC is ultimately made by transurethral resection of the bladder tumour (TURBT). Cystoscopy should be performed in all patients, and the aspect, number, shape, size, and location of the tumour should be documented. Ultrasonography and/or intravenous urography/computed tomography-urogram should only be used in select patients with multiple or trigonal tumours. A repeat TURBT is recommended in high-grade T1 tumours or if the initial resection was incomplete and/or when there is no muscle in the specimen.

AB - Context: Early detection and diagnosis improves both the management and survival of patients with non-muscle invasive bladder cancer (NMIBC). Objective: To provide a review of current approaches to the diagnosis of NMIBC as well as practical recommendations. Evidence acquisition: A committee of internationally renowned leaders in bladder cancer management, known as the International Bladder Cancer Group (IBCG), was convened in October 2006 to review current literature surrounding the diagnosis of NMIBC as well as the current clinical practice guidelines of the European Association of Urology (EAU), the First International Consultation of Bladder Tumours (FICBT), the National Comprehensive Cancer Network (NCCN), and the American Urological Association (AUA). Following the inaugural meeting in October 2006, the IBCG met on three subsequent occasions to exchange ideas and develop uniform and practical recommendations for the diagnosis of NMIBC. Evidence synthesis: The IBCG provided practical recommendations for the assessment and diagnosis of NMIBC. Conclusions: The diagnosis of NMIBC is ultimately made by transurethral resection of the bladder tumour (TURBT). Cystoscopy should be performed in all patients, and the aspect, number, shape, size, and location of the tumour should be documented. Ultrasonography and/or intravenous urography/computed tomography-urogram should only be used in select patients with multiple or trigonal tumours. A repeat TURBT is recommended in high-grade T1 tumours or if the initial resection was incomplete and/or when there is no muscle in the specimen.

KW - Bladder biopsies

KW - Bladder tumour markers

KW - Computed tomography

KW - Cystoscopy

KW - Diagnosis of non-muscle invasive bladder cancer

KW - Intravenous urography

KW - Magnetic resonance imaging

KW - Transurethral resection of the bladder tumour

KW - Ultrasonography

UR - http://www.scopus.com/inward/record.url?scp=51549109495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51549109495&partnerID=8YFLogxK

U2 - 10.1016/j.eursup.2008.07.005

DO - 10.1016/j.eursup.2008.07.005

M3 - Article

VL - 7

SP - 627

EP - 636

JO - European Urology, Supplements

JF - European Urology, Supplements

SN - 1569-9056

IS - 10

ER -